0QV2 Stock Overview
A medical device company, provides infection prevention solutions in orthopedics, urology, intravascular/critical care, dental, and wound care therapeutic areas in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Bactiguard Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 74.00 |
| 52 Week High | SEK 83.70 |
| 52 Week Low | SEK 60.40 |
| Beta | -0.22 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 8.88% |
| 3 Year Change | -61.05% |
| 5 Year Change | n/a |
| Change since IPO | 224.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0QV2 | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.3% | -2.2% |
| 1Y | 8.9% | -10.6% | 2.4% |
Return vs Industry: 0QV2 exceeded the UK Medical Equipment industry which returned -10.7% over the past year.
Return vs Market: 0QV2 exceeded the UK Market which returned -1.8% over the past year.
Price Volatility
| 0QV2 volatility | |
|---|---|
| 0QV2 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0QV2 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0QV2's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 217 | Christine Lind | www.bactiguard.com |
Bactiguard Holding AB (publ), a medical device company, provides infection prevention solutions in orthopedics, urology, intravascular/critical care, dental, and wound care therapeutic areas in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally. The company's infection prevention solutions reduce the risk of infections and the use of antibiotics. Its product portfolio consists of Bactiguard infection protection (BIP) Foley Catheter, an indwelling urinary catheter that reduces microbial adhesion; BIP Central Venous Catheter, which reduces the risk of catheter related bloodstream infection and antibiotics; BIP Endotracheal Tube, that reduces the ventilator associated pneumonia, antibiotics, and healthcare costs; BIP Endotracheal Tube Evac, a tube that combines the subglottic secretion drainage with coating to reduce microbial adhesion; and BIP Foley TempSensor, an indwelling urinary catheter that offers surveillance and infection prevention.
Bactiguard Holding AB (publ) Fundamentals Summary
| 0QV2 fundamental statistics | |
|---|---|
| Market cap | SEK 2.38b |
| Earnings (TTM) | -SEK 138.38m |
| Revenue (TTM) | SEK 203.99m |
11.7x
P/S Ratio-17.2x
P/E RatioIs 0QV2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0QV2 income statement (TTM) | |
|---|---|
| Revenue | SEK 203.99m |
| Cost of Revenue | SEK 49.21m |
| Gross Profit | SEK 154.78m |
| Other Expenses | SEK 293.16m |
| Earnings | -SEK 138.38m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
| Earnings per share (EPS) | -3.95 |
| Gross Margin | 75.88% |
| Net Profit Margin | -67.84% |
| Debt/Equity Ratio | 50.6% |
How did 0QV2 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/04/22 15:19 |
| End of Day Share Price | 2024/01/25 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bactiguard Holding AB (publ) is covered by 1 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Commissioned Research |